Ae Ri Ahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ae Ri Ahn has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Kyoung Min Kim
Departments of Pathology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, 20 Geonji-ro, Deokjin-gu, Jeonju City, Jeollabuk-Do 54907, Republic of Korea
11 shared publications - Kyu Yun Jang
Department of Pathology, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea
8 shared publications - Myoung Ja Chung
Department of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University–Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea
8 shared publications - Ho Sung Park
Department of Pathology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea
6 shared publications Myoung Ja Chung
4 shared publications- Jae Do Yang
Department of Surgery, Jeonbuk National University Medical School and Hospital, Jeonju 54907, Republic of Korea
3 shared publications
Latest Publications
- 10 November 2026
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 22
A Heterogeneous Breast Spindle Cell Tumor Revealed by Serial Imaging Follow-up: A Case Report of Sequentially Discordant Diagnoses of Desmoid-Type Fibromatosis and High-Grade Undifferentiated Sarcoma
Background: Breast soft-tissue tumors are rare and may present with overlapping imaging features, making accurate preoperative diagnosis challenging. Desmoid-Type Fibromatosis (DTF) is a locally aggressive, non-metastasizing fibroblastic tumor that can mimic breast malignancy because of its infiltrative growth pattern and irregular morphology. In contrast, high-grade undifferentiated sarcoma of the breast is an exceptionally rare but aggressive malignancy. We report a rare case of sequentially discordant diagnosis of DTF and high-grade undifferentiated sarcoma, highlighting the potential impact of intratumoral heterogeneity on radiologic-pathologic correlation. Case Presentation: A 44-year-old woman with metastatic hormone receptor-positive breast cancer underwent total mastectomy for a progressively enlarging breast mass demonstrating interval growth and chest wall involvement on serial imaging. Histopathologic examination of the mastectomy specimen revealed DTF with nuclear β-catenin positivity and a Ki-67 labeling index of approximately 30%. Three months later, a newly palpable mass developed at the operative site despite continued systemic therapy. Local excision revealed high-grade undifferentiated spindle cell sarcoma. Subsequent imaging demonstrated recurrent mass formation and persistent interval growth, and repeat excision confirmed recurrent undifferentiated sarcoma. Molecular analysis identified TP53, PIK3CA, and JAK2 variants Conclusion: This case highlights the diagnostic challenges posed by biologically heterogeneous spindle cell tumors of the breast. Atypical imaging findings and progressive growth, more aggressive than typically expected for DTF, raise the possibility of intratumoral heterogeneity, although this interpretation remains speculative without molecular confirmation. Such findings warrant careful radiologic-pathologic reassessment and serial imaging follow-up to guide management.
- 10 November 2026
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 22
A Heterogeneous Breast Spindle Cell Tumor Revealed by Serial Imaging Follow-up: A Case Report of Sequentially Discordant Diagnoses of Desmoid-Type Fibromatosis and High-Grade Undifferentiated Sarcoma
Background: Breast soft-tissue tumors are rare and may present with overlapping imaging features, making accurate preoperative diagnosis challenging. Desmoid-Type Fibromatosis (DTF) is a locally aggressive, non-metastasizing fibroblastic tumor that can mimic breast malignancy because of its infiltrative growth pattern and irregular morphology. In contrast, high-grade undifferentiated sarcoma of the breast is an exceptionally rare but aggressive malignancy. We report a rare case of sequentially discordant diagnosis of DTF and high-grade undifferentiated sarcoma, highlighting the potential impact of intratumoral heterogeneity on radiologic-pathologic correlation. Case Presentation: A 44-year-old woman with metastatic hormone receptor-positive breast cancer underwent total mastectomy for a progressively enlarging breast mass demonstrating interval growth and chest wall involvement on serial imaging. Histopathologic examination of the mastectomy specimen revealed DTF with nuclear β-catenin positivity and a Ki-67 labeling index of approximately 30%. Three months later, a newly palpable mass developed at the operative site despite continued systemic therapy. Local excision revealed high-grade undifferentiated spindle cell sarcoma. Subsequent imaging demonstrated recurrent mass formation and persistent interval growth, and repeat excision confirmed recurrent undifferentiated sarcoma. Molecular analysis identified TP53, PIK3CA, and JAK2 variants Conclusion: This case highlights the diagnostic challenges posed by biologically heterogeneous spindle cell tumors of the breast. Atypical imaging findings and progressive growth, more aggressive than typically expected for DTF, raise the possibility of intratumoral heterogeneity, although this interpretation remains speculative without molecular confirmation. Such findings warrant careful radiologic-pathologic reassessment and serial imaging follow-up to guide management.
- Open Access
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (1) , 63-75
Prognostic Impact of Radiologic and Pathologic Features on the Development of Progressive Pulmonary Fibrosis in Patients With Interstitial Lung Disease Other Than Idiopathic Pulmonary Fibrosis
Cho HR, et al. Korean J Radiol. 2026 Jan;27(1):63-75. https://doi.org/10.3348/kjr.2025.0977
- 1 January 2026
- Published by XMLink in Korean Journal of Radiology
- Vol. 27 (1) , 63-75
Open AccessPrognostic Impact of Radiologic and Pathologic Features on the Development of Progressive Pulmonary Fibrosis in Patients With Interstitial Lung Disease Other Than Idiopathic Pulmonary Fibrosis
Cho HR, et al. Korean J Radiol. 2026 Jan;27(1):63-75. https://doi.org/10.3348/kjr.2025.0977
- Open Access
- 15 November 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (6) , 467-471
Primary thyroid diffuse large B-cell lymphoma: fine needle aspiration and histological correlation
Primary thyroid lymphoma (PTL) is a rare type of cancer that arises within the thyroid gland, representing about 2%–8% of all thyroid malignancies. Fine-needle aspiration cytology is commonly used as the first-line diagnostic approach for thyroid nodules and can assist in identifying PTL when suggestive features are present. Herein, we report the case of a 59-year-old female patient who presented with a rapidly enlarging anterior neck mass over 20 days. Clinically, the case was challenging to distinguish from anaplastic thyroid carcinoma because of the sudden enlargement of the neck mass. However, pathological examination confirmed the diagnosis of primary thyroid diffuse large B-cell lymphoma. Fine-needle aspiration cytology proved valuable in avoiding unnecessary surgical resection and guiding appropriate treatment. Additionally, we provide a brief review of the clinical and cytopathological features of primary thyroid lymphomas.
- 15 November 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (6) , 467-471
Open AccessPrimary thyroid diffuse large B-cell lymphoma: fine needle aspiration and histological correlation
Primary thyroid lymphoma (PTL) is a rare type of cancer that arises within the thyroid gland, representing about 2%–8% of all thyroid malignancies. Fine-needle aspiration cytology is commonly used as the first-line diagnostic approach for thyroid nodules and can assist in identifying PTL when suggestive features are present. Herein, we report the case of a 59-year-old female patient who presented with a rapidly enlarging anterior neck mass over 20 days. Clinically, the case was challenging to distinguish from anaplastic thyroid carcinoma because of the sudden enlargement of the neck mass. However, pathological examination confirmed the diagnosis of primary thyroid diffuse large B-cell lymphoma. Fine-needle aspiration cytology proved valuable in avoiding unnecessary surgical resection and guiding appropriate treatment. Additionally, we provide a brief review of the clinical and cytopathological features of primary thyroid lymphomas.
- Open Access
- 1 November 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (11) , 7870-7880
Expression and role of PD-L1 and SOX10 in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer and second leading cause of cancer-related mortality worldwide. This study aimed to investigate programmed death ligand-1 (PD-L1) and SRY-box transcription factor 10 (SOX10) expression in 191 HCC specimens and to analyze their association with clinicopathological features. Methods: Formalin-fixed, paraffin-embedded HCC specimens were assessed for PD-L1 and SOX10 expression using immunohistochemical staining. Clinicopathological features were obtained from medical records and by reviewing hematoxylin and eosin-stained slides. Results: The proportions of PD-L1-positive and SOX10-positive groups were 13.1% and 46.1%, respectively. PD-L1 positivity was significantly associated with higher T classification (PConclusions: PD-L1 and SOX10 expression were associated with unfavorable prognostic factors as well as shorter OS and RFS. Further investigation is warranted to elucidate the molecular pathways through which SOX10 may regulate PD-L1 expression and to explore implications for immunotherapy response in patients with HCC.
- 1 November 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (11) , 7870-7880
Open AccessExpression and role of PD-L1 and SOX10 in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer and second leading cause of cancer-related mortality worldwide. This study aimed to investigate programmed death ligand-1 (PD-L1) and SRY-box transcription factor 10 (SOX10) expression in 191 HCC specimens and to analyze their association with clinicopathological features. Methods: Formalin-fixed, paraffin-embedded HCC specimens were assessed for PD-L1 and SOX10 expression using immunohistochemical staining. Clinicopathological features were obtained from medical records and by reviewing hematoxylin and eosin-stained slides. Results: The proportions of PD-L1-positive and SOX10-positive groups were 13.1% and 46.1%, respectively. PD-L1 positivity was significantly associated with higher T classification (PConclusions: PD-L1 and SOX10 expression were associated with unfavorable prognostic factors as well as shorter OS and RFS. Further investigation is warranted to elucidate the molecular pathways through which SOX10 may regulate PD-L1 expression and to explore implications for immunotherapy response in patients with HCC.
- 13 February 2025
- Published by Wiley in Pathology International
- Vol. 75 (3) , 171-173
Pathological predictor of progressive pulmonary fibrosis
- 13 February 2025
- Published by Wiley in Pathology International
- Vol. 75 (3) , 171-173
Pathological predictor of progressive pulmonary fibrosis
- Open Access
- 3 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (1) , e41228
PD-L1 and ALK expressions in stages III and IV colorectal cancer and their correlation with clinicopathological features
Colorectal cancer (CRC) is a type of cancer with a high recurrence rate. Studies are in the progress to identify effective treatments for CRC patients. We aimed to compare the expression of programmed death-ligand 1 (PD-L1) and anaplastic lymphoma kinase (ALK) in stages III and IV CRC patients and evaluate the clinicopathological significance associated with their expression. A total of 169 stages III and IV CRC specimens was tested for ALK (D5F3) and PD-L1 (SP142 and SP263) expression using immunohistochemistry on formalin-fixed paraffin-embedded specimens. Clinicopathological characteristics were obtained through a review of the medical records and hematoxylin and eosin slides. Expression of PD-L1 SP142 and PD-L1 SP263 was detected in 17.8% and 28.4% of CRC patients, respectively. ALK D5F3 expression was detected in 4 cases. PD-L1 SP142 expression was significantly correlated with tumor site and serum carcinoembryonic antigen (CEA) level. PD-L1 SP263 expression was associated with serum tumor marker level and tumor-infiltrating lymphocytes. In univariate analysis, PD-L1 expression was correlated with shorter survival in CRC patients. PD-L1 SP263 expression was an independent indicator of shorter survival in multivariate analysis. PD-L1 expression was associated with poor prognostic factors, including shorter survival. Further investigation is needed to understand the mechanisms of the association between PD-L1 expression and unfavorable CRC prognosis.
- 3 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (1) , e41228
Open AccessPD-L1 and ALK expressions in stages III and IV colorectal cancer and their correlation with clinicopathological features
Colorectal cancer (CRC) is a type of cancer with a high recurrence rate. Studies are in the progress to identify effective treatments for CRC patients. We aimed to compare the expression of programmed death-ligand 1 (PD-L1) and anaplastic lymphoma kinase (ALK) in stages III and IV CRC patients and evaluate the clinicopathological significance associated with their expression. A total of 169 stages III and IV CRC specimens was tested for ALK (D5F3) and PD-L1 (SP142 and SP263) expression using immunohistochemistry on formalin-fixed paraffin-embedded specimens. Clinicopathological characteristics were obtained through a review of the medical records and hematoxylin and eosin slides. Expression of PD-L1 SP142 and PD-L1 SP263 was detected in 17.8% and 28.4% of CRC patients, respectively. ALK D5F3 expression was detected in 4 cases. PD-L1 SP142 expression was significantly correlated with tumor site and serum carcinoembryonic antigen (CEA) level. PD-L1 SP263 expression was associated with serum tumor marker level and tumor-infiltrating lymphocytes. In univariate analysis, PD-L1 expression was correlated with shorter survival in CRC patients. PD-L1 SP263 expression was an independent indicator of shorter survival in multivariate analysis. PD-L1 expression was associated with poor prognostic factors, including shorter survival. Further investigation is needed to understand the mechanisms of the association between PD-L1 expression and unfavorable CRC prognosis.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (4) , 288-294
Desmoid-Type Fibromatosis Masquerading as Disease Progression in Metastatic Breast Cancer in a Patient on Ribociclib Therapy: A Case Report
Ahn HR, et al. J Breast Cancer. 2025 Aug;28:e27. https://doi.org/10.4048/jbc.2025.0107
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (4) , 288-294
Open AccessDesmoid-Type Fibromatosis Masquerading as Disease Progression in Metastatic Breast Cancer in a Patient on Ribociclib Therapy: A Case Report
Ahn HR, et al. J Breast Cancer. 2025 Aug;28:e27. https://doi.org/10.4048/jbc.2025.0107
- Open Access
- 13 December 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (50) , e40995
Intravascular large B-cell lymphoma arising in the pituitary gland: A case report
Rationale: Primary pituitary lymphoma is defined as a lymphoma that develops only in the pituitary gland without involvement of other areas. Patient concerns: We present the case of a 61-year-old female patient who underwent an endonasal transsphenoidal approach for the preoperative diagnosis of a pituitary macroadenoma based on radiological findings. Diagnoses: Microscopically, the capillaries were distended by tumor cells. The high-magnification view showed large cells with vesicular nuclei and single or multiple prominent nucleoli, with mitotic figures often observed within the intravascular space. Interventions: Immunohistochemical staining showed strong positivity for CD45 and pan-B cell markers such as CD19 and CD20. The postoperative diagnosis was intravascular large B-cell lymphoma of the pituitary gland. Outcomes: Next-generation sequencing revealed alterations in 12 genes: ARID5B, BCL2, CD79B, ETV6, HLA-B, LRRC7, MYD88, PIM1, POT1, PTPN11, RASA1, and SRSF2. Lessons: To our knowledge, this is the first case report of pituitary intravascular large B-cell lymphoma.
- 13 December 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (50) , e40995
Open AccessIntravascular large B-cell lymphoma arising in the pituitary gland: A case report
Rationale: Primary pituitary lymphoma is defined as a lymphoma that develops only in the pituitary gland without involvement of other areas. Patient concerns: We present the case of a 61-year-old female patient who underwent an endonasal transsphenoidal approach for the preoperative diagnosis of a pituitary macroadenoma based on radiological findings. Diagnoses: Microscopically, the capillaries were distended by tumor cells. The high-magnification view showed large cells with vesicular nuclei and single or multiple prominent nucleoli, with mitotic figures often observed within the intravascular space. Interventions: Immunohistochemical staining showed strong positivity for CD45 and pan-B cell markers such as CD19 and CD20. The postoperative diagnosis was intravascular large B-cell lymphoma of the pituitary gland. Outcomes: Next-generation sequencing revealed alterations in 12 genes: ARID5B, BCL2, CD79B, ETV6, HLA-B, LRRC7, MYD88, PIM1, POT1, PTPN11, RASA1, and SRSF2. Lessons: To our knowledge, this is the first case report of pituitary intravascular large B-cell lymphoma.
- Open Access
- 15 November 2024
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 58 (6) , 341-345
Colorectal cancer with a germline BRCA1 variant inherited paternally: a case report
BRCA genes have well-known associations with breast and ovarian cancers. However, variations in the BRCA gene, especially germline variations, have also been reported in colorectal cancer (CRC). We present the case of a rectal cancer with a germline BRCA1 variation inherited from the paternal side. A 39-year-old male was admitted with rectal cancer. The patient underwent surgical resection and the pathologic diagnosis was adenocarcinoma. Next-generation sequencing was performed and a BRCA1 variant was detected. Reviewing the public database and considering the young age of the patient, the variant was suggested to be germline. The patient’s father had had prostate cancer and next-generation sequencing testing revealed an identical BRCA1 variant. In the BRCA cancer group, there is relatively little attention paid to male cancers. The accumulation of male CRC cases linked to BRCA variations may help clarify the potential pathological relationship between the two.
- 15 November 2024
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 58 (6) , 341-345
Open AccessColorectal cancer with a germline BRCA1 variant inherited paternally: a case report
BRCA genes have well-known associations with breast and ovarian cancers. However, variations in the BRCA gene, especially germline variations, have also been reported in colorectal cancer (CRC). We present the case of a rectal cancer with a germline BRCA1 variation inherited from the paternal side. A 39-year-old male was admitted with rectal cancer. The patient underwent surgical resection and the pathologic diagnosis was adenocarcinoma. Next-generation sequencing was performed and a BRCA1 variant was detected. Reviewing the public database and considering the young age of the patient, the variant was suggested to be germline. The patient’s father had had prostate cancer and next-generation sequencing testing revealed an identical BRCA1 variant. In the BRCA cancer group, there is relatively little attention paid to male cancers. The accumulation of male CRC cases linked to BRCA variations may help clarify the potential pathological relationship between the two.
- Open Access
- 5 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (27) , e38791
Attenuated adenomatous polyposis with MSH6 variation: Two case reports
Rationale: Adenomatous polyposis (AP) is a genetic disorder characterized by the occurrence of numerous adenomatous polyps in the colon and rectum and can be classified into classical AP and attenuated AP (AAP). AAP is diagnosed when the number of observed adenomas is between 10 and 99. The detection of AAP is significantly increasing mainly due to the improvement of the imaging technique and application of the screening program for colorectal cancer detection. Currently, the germline variations of the APC and MUTYH genes are reported as the main cause of classical AP. However, the underlying genetic basis of AAP is not well understood. In this study, we report 2 cases of AAP with MSH6 variations. Patient concerns: Both patients visited the hospital after multiple polyps were detected during colonoscopies conducted as part of their health checkups. Diagnoses: The 2 patients were diagnosed with AAP through colonoscopic examination at our hospital. Interventions: The 2 received genetic consultation; and, for follow-up purposes, both patients agreed to be tested for an underlying genetic condition through next generation sequencing. And germline MSH6 variations were detected in both AAP patients. Outcomes: There was no recurrence for both patients for 3 years follow-up. Lessons: Minor portion of AAP can cause by genetic mutation in MSH6, and further research is needed.
- 5 July 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (27) , e38791
Open AccessAttenuated adenomatous polyposis with MSH6 variation: Two case reports
Rationale: Adenomatous polyposis (AP) is a genetic disorder characterized by the occurrence of numerous adenomatous polyps in the colon and rectum and can be classified into classical AP and attenuated AP (AAP). AAP is diagnosed when the number of observed adenomas is between 10 and 99. The detection of AAP is significantly increasing mainly due to the improvement of the imaging technique and application of the screening program for colorectal cancer detection. Currently, the germline variations of the APC and MUTYH genes are reported as the main cause of classical AP. However, the underlying genetic basis of AAP is not well understood. In this study, we report 2 cases of AAP with MSH6 variations. Patient concerns: Both patients visited the hospital after multiple polyps were detected during colonoscopies conducted as part of their health checkups. Diagnoses: The 2 patients were diagnosed with AAP through colonoscopic examination at our hospital. Interventions: The 2 received genetic consultation; and, for follow-up purposes, both patients agreed to be tested for an underlying genetic condition through next generation sequencing. And germline MSH6 variations were detected in both AAP patients. Outcomes: There was no recurrence for both patients for 3 years follow-up. Lessons: Minor portion of AAP can cause by genetic mutation in MSH6, and further research is needed.